Genetics and molecular biology: Macrophage ACAT depletion - Mechanisms of atherogenesis

Current Opinion in Lipidology

Volumn 17, Issue 1, 2006, Pages 85-88

  Akopian, David ^a   Medh, Jheem D ^a  

^a CALIFORNIA STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL ACYLTRANSFERASE; CHOLESTEROL ACYLTRANSFERASE INHIBITOR;

APOPTOSIS; ATHEROGENESIS; ATHEROSCLEROSIS; EDITORIAL; GENE DELETION; GENETICS; HUMAN; HYPERCHOLESTEROLEMIA; MOLECULAR BIOLOGY; MOLECULAR MECHANICS; NONHUMAN; PERITONEUM MACROPHAGE; PRIORITY JOURNAL; PROTEIN DEPLETION;

EID: 30744466140     PISSN: 09579672     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.mol.0000203192.45649.ba     Document Type: Editorial

References (11)

1. Buhman KF, Accad M, Farese RV Jr. Mammalian acyl-CoA:cholesterol aoyltransferases. Biochim Biophys Acta 2000; 1529:142-154.
2. Leon C, Hill JS, Wasan KM. Potential role of acyl-coenzyme A:cholesterol transferase (ACAT) inhibitors as hypolipidemic and antiatherosclerosis drugs. Pharm Res 2005; 22:1578-1588.
3. Accad M, Smith SJ, Newland DL, et al. Massive xanthomatosis and altered composition of atherosclerotic lesions in hyperlipidemic mice lacking acyl CoA:cholesterol acyltransferase 1. J Clin Invest 2000; 105:711-719.
4. Fazio S, Major AS, Swift LL, et al. Increased atherosclerosis in LDL receptor-null mice lacking ACAT1 in macrophages. J Clin Invest 2001; 107:163-171.
5. Warner GJ, Stoudt G, Bamberger M, et al. Cell toxicity induced by inhibition of acyl coenzyme A:cholesterol acyltransferase and accumulation of unesterified cholesterol. J Biol Chem 1995; 270:5772-5778.
6. Su YR, Dove DE, Major AS, et al. Reduced ABCA1-mediated cholesterol efflux and accelerated atherosclerosis in apolipoprotein E-deficient mice lacking macrophage-derived ACAT1. Circulation 2005; 111:2373-2381.
7. Dove DE, Su YR, Zhang W, et al. ACAT1 deficiency disrupts cholesterol efflux and alters cellular morphology in macrophages. Arterioscler Thromb Vasc Biol 2005; 25:128-134.
8. Dove DE, Su YR, Swift LL, et al. ACAT1 deficiency increases cholesterol synthesis in mouse peritoneal macrophages. Atherosclerosis, 2005; Sept 3. PMID: 16144700 [Epub ahead of print].
9. Freeman NE, Rusinol AE, Linton M, et al. Acyl-coenzyme A:cholesterol acyltransferase promotes oxidized LDL/oxysterol-induced apoptosis in macrophages. J Lipid Res 2005; 46:1933-1943.
10. Kharbanda RK, Wallace S, Walton B, et al. Systemic acyl-CoA:cholesterol acyltransferase inhibition reduces inflammation and improves vascular function in hypercholesterolemia. Circulation 2005; 111:804-807.
11. Rong JX, Kusunoki J, Oelkers P, et al. Acyl-coenzyme A (CoA):cholesterol acyltransferase inhibition in rat and human aortic smooth muscle cells is nontoxic and retards foam cell formation. Arterioscler Thromb Vasc Biol 2005; 25:122-127.